title: DO IT Trial: vitamin D Outcomes and Interventions in Toddlers - a TARGet Kids! randomized controlled trial.
abstract: BACKGROUND
  Vitamin D levels are alarmingly low (<75 nmol/L) in 65-70% of North American children older than 1 year. An increased risk of viral upper respiratory tract infections (URTI), asthma-related hospitalizations and use of anti-inflammatory medication have all been linked with low vitamin D. No study has determined whether wintertime vitamin D supplementation can reduce the risk of URTI and asthma exacerbations, two of the most common and costly illnesses of early childhood. The objectives of this study are: 1) to compare the effect of 'high dose' (2000 IU/day) vs. 'standard dose' (400 IU/day) vitamin D supplementation in achieving reductions in laboratory confirmed URTI and asthma exacerbations during the winter in preschool-aged Canadian children; and 2) to assess the effect of 'high dose' vitamin D supplementation on vitamin D serum levels and specific viruses that cause URTI.
  
  
  METHODS
  This study is a pragmatic randomized controlled trial. Over 4 successive winters we will recruit 750 healthy children 1-5 years of age. Participating physicians are part of a primary healthcare research network called TARGet Kids!. Children will be randomized to the 'standard dose' or 'high dose' oral supplemental vitamin D for a minimum of 4 months (200 children per group). Parents will obtain a nasal swab from their child with each URTI, report the number of asthma exacerbations and complete symptom checklists. Unscheduled physician visits for URTIs and asthma exacerbations will be recorded. By May, a blood sample will be drawn to determine vitamin D serum levels. The primary analysis will be a comparison of URTI rate between study groups using a Poisson regression model. Secondary analyses will compare vitamin D serum levels, asthma exacerbations and the frequency of specific viral agents between groups.
  
  
  CONCLUSIONS
  Identifying whether vitamin D supplementation of preschoolers can reduce wintertime viral URTIs and asthma exacerbations and what dose is optimal may reduce population wide morbidity and associated health care and societal costs. This information will assist in determining practice and health policy recommendations related to vitamin D supplementation in healthy Canadian preschoolers.
authors: The Applied Health Research Centre of the Li Ka Shing Knowledge Institute of St, Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. jonathon.maguire@utoronto.ca.
authors: Jonathon L
authors: JL
authors: Maguire
authors: Catherine S
authors: CS
authors: Birken
authors: Mark B
authors: MB
authors: Loeb
authors: Muhammad
authors: M
authors: Mamdani
authors: Kevin
authors: K
authors: Thorpe
authors: Jeffrey S
authors: JS
authors: Hoch
authors: Tony
authors: T
authors: Mazzulli
authors: Cornelia M
authors: CM
authors: Borkhoff
authors: Colin
authors: C
authors: Macarthur
authors: Patricia C
authors: PC
authors: Parkin
mesh_terms: D001249:Asthma / Q000517:prevention & control*; D002170:Canada; D002675:Child, Preschool; D019587:Dietary Supplements; D018450:Disease Progression; D006801:Humans; D007223:Infant; D012141:Respiratory Tract Infections / Q000517:prevention & control*; D012621:Seasons; D016896:Treatment Outcome; D014807:Vitamin D / Q000008:administration & dosage*; D014815:Vitamins / Q000008:administration & dosage*
chemical_list: D014815:Vitamins; D014807:Vitamin D